Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

MariMed Reports Q2 2025 Financial Results

NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...

  • Verano Holdings Corp.

Verano Holdings Corp Reports Q2 2025 Financial Results

CHICAGO – Verano Holdings Corp., a multi-state Cannabis operator, released its financial results for the second quarter of 2025, reflecting a period of operational streamlining amid market challenges. The consolidated financial statements, prepared under U.S. ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

MariMed Reports Q2 2025 Financial Results

NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...

Maryland Governor Expands Cannabis Pardons

LOS ANGELES- Maryland Governor Wes Moore has announced an additional round of approximately 6,938 pardons for individuals previously convicted of simple cannabis possession, following a 2024 executive order that granted clemency to over 175,000 convictions ...

High-Potency Cannabis Strains Impact Legal and Health Systems

LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...

New Zealand Approves Psilocybin for Medicinal Use

LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...

MJ and MSOS ETFs Signal High Upside on U.S. Legalization Outlook

LOS ANGELES- Investment in cannabis-focused ETFs such as Amplify’s MJ and AdvisorShares’ MSOS reflects growing investor anticipation of federal legalization-driven expansion, even amid pronounced volatility and structural headwinds. Analysts argue that rescheduling cannabis from Schedule I ...

Canadian Cannabis Producers Expand Exports

LOS ANGELES- Canada’s licensed cannabis sector continues its move toward international markets, driven by strong global demand, especially for medical cannabis. During the 2023–24 fiscal year, Canada exported approximately CA$218 million of medical cannabis for commercial ...

Emerging Programs Aim to Democratize Cannabis Cultivation

LOS ANGELES- Governments, industry groups, and educational institutions are launching a wave of initiatives aimed at lowering barriers to entry in cannabis cultivation and production—efforts collectively referred to as “democratizing cannabis production.” These programs focus ...

Subscribe To Our Newsletter

Go to Top